Skip to content

Investigating the Effect of Vitamins E, C and D on Symptoms of Withdrawal Syndrome

Evaluation of the Effects of Vitamins E, C and D Separately and Synergistically on Pain and Anxiety Score Caused by Withdrawal Syndrome in Patients Who are Candidate for Withdrawal: A Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200721048159N6
Enrollment
125
Registered
2023-07-08
Start date
2023-10-23
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety and pain caused by drug withdrawal in addicted patients. Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances

Interventions

Intervention 1: Control group: The control group includes samples that do not receive any vitamins. Intervention 2: Intervention group1: Intervention group: Patients who, in addition to receiving stan

Sponsors

Khoram-Abad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Confirmed diagnosis of opioids and stimulants substances Men over 18 years old The emergence of withdrawal syndrome based on the diagnosis of a psychiatrist a score of at least 3 in the VAS test Performing a TLC test to detect consumption (methadone, morphine, amphetamine and etc..) Consent to participating in the study

Exclusion criteria

Exclusion criteria: Taking multivitamin, mineral and antioxidant supplements in the last 3 months before starting the intervention Liver or kidney failure

Design outcomes

Primary

MeasureTime frame
Pain caused by drug withdrawal according to VAS test. Timepoint: Before the start of the intervention and daily for ten days after the start of the intervention. Method of measurement: Test VAS.;Examining anxiety caused by quitting addiction. Timepoint: Before the start of the intervention and daily for ten days after the start of the intervention. Method of measurement: Beck's anxiety questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactForouzan Ahmadpour

Khoram-Abad University of Medical Sciences

ahmadpourforoz@yahoo.com+98 66 3330 0661

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026